Helicobacter pylori cell wall and cell envelope components (H. pylori cell wall)

The Helicobacter pylori cell wall and cell envelope components constitute a complex, multi-layered barrier essential for the bacterium's survival in the highly acidic environment of the human stomach (StatPearls, 2023). This structure includes an inner cytoplasmic membrane, a thin peptidoglycan layer, and an outer membrane containing unique lipopolysaccharides and outer membrane proteins (OMPs) such as BabA and SabA (NCBI, 2011). These components are vital for maintaining structural integrity, providing osmotic protection, and facilitating adherence to the gastric epithelium, which is a prerequisite for colonization and subsequent pathogenesis (Microbiology Spectrum, 2018). As a therapeutic target, the cell wall is primarily addressed by beta-lactam antibiotics like amoxicillin, which inhibit peptidoglycan synthesis by targeting penicillin-binding proteins (PBPs), leading to bacterial lysis (PubMed, 2019). Additionally, bismuth-based compounds interact with the cell envelope to cause structural damage and inhibit bacterial enzymes (NIH, 2020). Effective targeting of these components is a cornerstone of therapy for H. pylori-associated conditions, including chronic gastritis, peptic ulcers, and gastric adenocarcinoma, though the emergence of resistance through structural modifications remains a significant clinical challenge (StatPearls, 2023).

Other names

Helicobacter pylori cell envelopeHelicobacter pylori peptidoglycan layerHelicobacter pylori outer membraneHelicobacter pylori lipopolysaccharide

Drugs targeting the H. pylori cell wall primarily act by inhibiting the synthesis of the peptidoglycan layer. For instance, beta-lactam antibiotics like amoxicillin bind to penicillin-binding proteins (PBPs), preventing the cross-linking of peptidoglycan chains, which leads to osmotic instability and bacterial lysis (PubMed, 2019). Bismuth salts contribute by disrupting the cell membrane and wall structure, further compromising bacterial integrity (NIH, 2020).